Alzheimer’s disease (AD) represents the most common form of dementia, affecting millions of people globally. Characterized by a progressive neurodegenerative process, AD leads to a severe decline in cognitive function, eventually disrupting emotional regulation and triggering a cascade of neuropsychiatric symptoms (NPS). Among these symptoms, agitation, commonly referred to as Agit-AD, presents one of the … Leggi tutto Synthetic Cannabis Eases Agitation in Alzheimer’s – Exploring Agitation in Alzheimer’s Disease: Current Insights, Challenges and Therapeutic Advances in the Role of Cannabinoids